Cantor Fitzgerald Analysts Give BioDelivery Sciences International (BDSI) a $5.00 Price Target


The brokerage currently has a buy rating on the specialty pharmaceutical company's stock. Other analysts have also recently issued research reports about the stock.



from Biotech News